Zirgan Side Effects: What to Expect and When to Call Your Doctor

Starting a new eye medication can feel a little uncertain, especially when side effects start right away. Zirgan (ganciclovir ophthalmic gel 0.15%) causes blurry vision in up to 60% of patients immediately after application — but that's expected and usually resolves quickly. Other side effects are less common and may require you to call your doctor.

Here's a complete breakdown of Zirgan side effects so you know what's normal and what's a warning sign.

Common Side Effects of Zirgan

These side effects were reported in clinical trials and are considered expected reactions. They generally improve over time or resolve after each dose:

Blurred vision (60%) — This is the most frequently reported side effect. It occurs because of the gel formulation of Zirgan and is temporary, usually clearing within minutes of application. Avoid driving or operating machinery immediately after each dose.

Eye irritation (20%) — Some stinging, burning, or discomfort upon application. Mild irritation that resolves shortly after dosing is normal.

Punctate keratitis (5%) — Small superficial corneal lesions that can cause irritation. This is monitored by your doctor during follow-up visits.

Conjunctival hyperemia (5%) — Redness of the white of the eye (the conjunctiva). This can look alarming but is often a normal response. It's different from the redness caused by your underlying infection.

Is Blurry Vision After Zirgan Normal?

Yes — blurry vision immediately after applying Zirgan is completely normal and expected. The gel formulation creates a temporary film over the eye surface that blurs vision for a few minutes after each dose. This clears naturally as the gel spreads and is absorbed. Most patients find the blurring peaks at about 1–2 minutes after application and resolves within 5 minutes. Plan your dosing schedule around activities that require clear vision (like driving) — apply the drop at a time when you don't need to drive or do close-vision work immediately.

When Should You Call Your Doctor?

Contact your eye care provider if you experience any of the following:

Increasing pain in the eye — Pain that gets worse during treatment may signal the infection spreading deeper or another problem.

Redness or itching that worsens — Redness that increases rather than gradually improving over the first few days of treatment should be evaluated.

Blurred vision that doesn't clear between doses — Persistent blurring (not the 5-minute post-dose blur) that doesn't resolve between applications may indicate a problem.

Symptoms not improving after 7 days — Most dendritic ulcers resolve within 7 days of treatment. If you're not seeing improvement, your doctor needs to reassess.

Allergic reactions — Signs include significant swelling of the eyelids, hives, or difficulty breathing. This is rare but requires immediate medical attention.

How Does Zirgan Compare to Older Eye Antivirals in Terms of Side Effects?

Zirgan has a notably better tolerability profile compared to trifluridine (generic Viroptic), the older standard topical treatment. In pooled clinical trial data:

Eye irritation: Zirgan 25.6% vs trifluridine 46.2%

Punctate keratitis: Zirgan 8.8% vs trifluridine 16%

Blurred vision: Zirgan 57.8% vs trifluridine 71.3%

Zirgan's lower toxicity is partly because it is selective for virus-infected cells — it's inactive in healthy corneal cells. This selectivity spares the normal ocular surface from drug-related damage.

Safety Tips for Using Zirgan

Wash your hands thoroughly before applying each dose

Do not allow the tube tip to touch your eye, fingers, or any surface

Do not wear contact lenses during treatment

Complete the full course even when symptoms improve — stopping early increases recurrence risk

Store at room temperature (59°F–77°F) — do not freeze

For information on Zirgan drug interactions, see: Zirgan Drug Interactions: What to Avoid. And if you're still searching for Zirgan in stock, medfinder can help you locate it near you.